Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome

Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome

BackgroundThe number of intratympanic gentamicin (ITG) injections needed to achieve vertigo control in patients with intractable Ménière's disease (MD) may vary from a single dose to several instillations. Changes in different vestibular test results have been used to define an endpoint of trea...

Full description

Bibliographic Details
Main Authors: Ricardo Wegmann-Vicuña, Raquel Manrique-Huarte, Diego Calavia-Gil, Eduardo Martín-Sanz, Pedro Marques, Nicolas Perez-Fernandez
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Neurology
Subjects:
vertigo
Ménière's disease
inner ear
ototoxicity
hearing loss
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.808570/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.808570/full

Similar Items